Xu He

1.2k total citations
49 papers, 912 citations indexed

About

Xu He is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Xu He has authored 49 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Hepatology and 11 papers in Cancer Research. Recurrent topics in Xu He's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer Mechanisms and Therapy (7 papers) and Nanoplatforms for cancer theranostics (5 papers). Xu He is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer Mechanisms and Therapy (7 papers) and Nanoplatforms for cancer theranostics (5 papers). Xu He collaborates with scholars based in China, Macao and France. Xu He's co-authors include Ligong Lu, Meixiao Zhan, Bao‐Shan Hu, Wei Zhao, Yong Li, Jianwen Huang, Youbin Zheng, Yanjun Cao, Nan Wang and Langchong He and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of The Electrochemical Society and Chemical Engineering Journal.

In The Last Decade

Xu He

45 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu He China 19 358 281 213 212 197 49 912
Kaiwen Hu China 14 260 0.7× 146 0.5× 186 0.9× 208 1.0× 137 0.7× 78 892
Yongsheng Ge China 22 542 1.5× 207 0.7× 236 1.1× 195 0.9× 146 0.7× 50 1.0k
Peng Gong China 21 467 1.3× 216 0.8× 399 1.9× 53 0.3× 158 0.8× 68 1.2k
Wenxi Li China 14 473 1.3× 194 0.7× 142 0.7× 46 0.2× 339 1.7× 51 951
Dong‐Sheng Huang China 13 317 0.9× 140 0.5× 139 0.7× 56 0.3× 120 0.6× 31 671
Xuefeng Xia China 14 363 1.0× 257 0.9× 192 0.9× 37 0.2× 109 0.6× 33 777
Muxing Kang China 19 579 1.6× 272 1.0× 328 1.5× 35 0.2× 154 0.8× 33 1.1k
Amudha Deivasigamani Singapore 14 561 1.6× 311 1.1× 203 1.0× 57 0.3× 80 0.4× 24 912
Zishu Wang China 17 484 1.4× 300 1.1× 222 1.0× 62 0.3× 53 0.3× 80 911
Jiaqi Wang China 15 229 0.6× 133 0.5× 321 1.5× 61 0.3× 82 0.4× 46 767

Countries citing papers authored by Xu He

Since Specialization
Citations

This map shows the geographic impact of Xu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu He more than expected).

Fields of papers citing papers by Xu He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu He. The network helps show where Xu He may publish in the future.

Co-authorship network of co-authors of Xu He

This figure shows the co-authorship network connecting the top 25 collaborators of Xu He. A scholar is included among the top collaborators of Xu He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu He. Xu He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xu, et al.. (2025). State of Health Estimation for Lithium-Ion Batteries Based on Global Feature Extraction and KPCA-ISSA-LSSVM Model. Journal of The Electrochemical Society. 172(11). 110525–110525. 1 indexed citations
2.
Xia, Lianghui, Yujie Liu, Kang Hui Lim, et al.. (2025). Stretched Pd-CoOx Interfaces-Induced Oxygen Vacancy Consecutive Activation Realizes Light Alkane Efficacious Destruction. ACS ES&T Engineering. 5(5). 1226–1241.
3.
Xiao, Fengfeng, Yongkang Liu, Yanhong Su, et al.. (2024). Biodegradable Poly(amino acid)–Bismuth Nanotheranostic Agents for CT/MR Imaging and Photothermal–Chemodynamic Synergistic Therapy. SHILAP Revista de lepidopterología. 1(5). 448–460. 9 indexed citations
6.
Jiang, Xinyu, Yihuan Liu, Li Liu, et al.. (2024). Mechanism of low-voltage electrostatic field on flavor retention in refrigerated sturgeon caviar: Insights from phospholipids. Food Chemistry X. 23. 101612–101612. 4 indexed citations
7.
Wang, Jingting, et al.. (2024). Omeprazole and its analogs exhibit insecticidal potencies as inhibitors of insect choline acetyltransferase. Pesticide Biochemistry and Physiology. 206. 106207–106207.
8.
Ding, Yanan, et al.. (2023). Learning and Investigation of the Role of Angiotensin-Converting Enzyme in Radiotherapy for Nasopharyngeal Carcinoma. Biomedicines. 11(6). 1581–1581. 1 indexed citations
9.
Zhan, Meixiao, Fengshuo Wang, Yao Liu, et al.. (2023). Dual‐Cascade Activatable Nanopotentiators Reshaping Adenosine Metabolism for Sono‐Chemodynamic‐Immunotherapy of Deep Tumors. Advanced Science. 10(10). e2207200–e2207200. 87 indexed citations
10.
He, Xu, et al.. (2023). Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus. Journal of Translational Medicine. 21(1). 688–688. 9 indexed citations
11.
Zhao, Wei, Ying Xu, Meixiao Zhan, et al.. (2020). Circulating tumor DNA as a potential prognostic and predictive biomarker during interventional therapy of unresectable primary liver cancer. Journal of Gastrointestinal Oncology. 11(5). 1065–1077. 19 indexed citations
12.
Liu, Yongkang, et al.. (2016). An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients. Hepatology International. 10(4). 640–646. 67 indexed citations
14.
Zheng, Youbin, Jianwen Huang, Meixiao Zhan, et al.. (2014). Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma. Tumor Biology. 35(11). 11473–11481. 15 indexed citations
15.
Zhan, Meixiao, Yong Li, Bao‐Shan Hu, et al.. (2014). Serum MicroRNA-210 as a Predictive Biomarker for Treatment Response and Prognosis in Patients with Hepatocellular Carcinoma undergoing Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology. 25(8). 1279–1287.e1. 31 indexed citations
16.
Cao, Yanjun, et al.. (2014). Chinese medicinal formula Guanxin Shutong capsule protects the heart against oxidative stress and apoptosis induced by ischemic myocardial injury in rats. Experimental and Therapeutic Medicine. 7(4). 1033–1039. 10 indexed citations
17.
Cao, Yanjun, Xu He, Nan Wang, & Langchong He. (2013). Effects of imperatorin, the active component from Radix Angelicae (Baizhi), on the blood pressure and oxidative stress in 2K,1C hypertensive rats. Phytomedicine. 20(12). 1048–1054. 52 indexed citations
18.
Zheng, Lei, Xu He, Weina Ma, et al.. (2012). Ta1722, an anti-angiogenesis inhibitor targeted on VEGFR-2 against human hepatoma. Biomedicine & Pharmacotherapy. 66(7). 499–505. 8 indexed citations
19.
Shi, Juan, Qiang Fu, Wang Chen, et al.. (2012). Comparative study of pharmacokinetics and tissue distribution of osthole in rats after oral administration of pure osthole and Libanotis buchtormensis supercritical extract. Journal of Ethnopharmacology. 145(1). 25–31. 27 indexed citations
20.
He, Xu, et al.. (2011). Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus. Cancer Biology & Therapy. 12(10). 865–871. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026